Our Mission
To detect cancer early, when it can be cured.
We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, groundbreaking technologies that can transform cancer care.
"More than 70 percent of cancer deaths result from cancers we don't screen for at all. Patients deserve better. GRAIL has developed groundbreaking technology to challenge the status quo and change the cancer screening paradigm. Our leadership in innovation, clinical evidence, and scalability position GRAIL at the forefront of multi-cancer early detection, to drive broad access and long-term growth in this new field."
Joshua Ofman, MD, MSHS
CEO